In recent weeks, global markets have been characterized by fluctuating indices and sector-specific movements, with notable advancements in the U.S. small-cap and mid-cap segments, while European ...
Corey Fishman, CEO of Iterum, expressed pride in achieving this FDA approval, emphasizing the drug’s potential to offer new hope for patients dealing with difficult-to-treat infections. The ...